BL
LH icon

Balentine LLC’s Labcorp LH Stock Holding History

Balentine LLC’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,339
Closed -$303K – 669
2022
Q1 		$303K Buy
1,339
+532
+66% +$125K 0.01% 425
2021
Q4 		$218K Buy
+807
New +$200K 0.01% 322
2020
Q3 		– Sell
-34
Closed -$5K – 552
2020
Q2 		$5K Sell
34
-2
-6% -$277 ﹤0.01% 727
2020
Q1 		$4K Buy
36
+15
+71% +$2.16K ﹤0.01% 508
2019
Q4 		$3K Hold
21
– – ﹤0.01% 505
2019
Q3 		$3K Hold
21
– – ﹤0.01% 613
2019
Q2 		$3K Buy
+21
New +$2.93K ﹤0.01% 592
2018
Q1 		– Sell
-570
Closed -$78K – 318
2017
Q4 		$78K Hold
570
– – 0.01% 223
2017
Q3 		$74K Hold
570
– – 0.01% 217
2017
Q2 		$76K Hold
570
– – 0.01% 200
2017
Q1 		$70K Buy
570
+93
+19% +$11K 0.01% 197
2016
Q4 		$53K Buy
477
+163
+52% +$18.1K 0.01% 204
2016
Q3 		$37K Hold
314
– – 0.01% 204
2016
Q2 		$35K Buy
+314
New +$33.8K 0.01% 186

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Balentine LLC's LH Position: Q2 2022 in Review

Balentine LLC sold out of Labcorp (LH) in Q2 2022, closing a stake of 1,339 shares — an estimated $303K sold.

Balentine LLC first reported a position in LH in Q2 2016 and held it in 14 quarters. The position peaked at $303K in Q1 2022. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Balentine LLC reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
  • Balentine LLC sold 1,339 Labcorp shares in Q2 2022, an estimated $303K.
  • Balentine LLC first reported a position in Labcorp in Q2 2016 and held it in 14 quarters.
  • Balentine LLC's Labcorp position peaked at $303K in Q1 2022.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Balentine LLC's 13F filing for Q2 2022, filed 15 Aug 2022.